Reopro 10mg Injection
By Reopro
Rx
5ml Injection in a Vial

Composition
Abciximab(10mg)

Manufacturer - Eli Lilly and Company India Pvt Ltd
Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Expires on or after
July, 2025

liver
When using Reopro 10mg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment of Reopro 10mg Injection. It is recommended to consult your doctor before using this medication. For individuals with severe liver disease, the use of Reopro 10mg Injection is not recommended.

kidney
Reopro 10mg Injection should be used carefully in patients with kidney disease. Adjustment in the dose might be necessary. Please consult your doctor. Avoid using Reopro 10mg Injection in severe kidney disease cases.

alcohol
Consult your doctor when consuming alcohol with Reopro 10mg Injection.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Reopro 10mg Injection.

pregnancy
Reopro 10mg Injection is not recommended during pregnancy as it may be unsafe. Limited human studies and animal studies have shown potential harm to the developing baby. Your doctor will carefully consider the benefits and risks before prescribing it. Please consult your doctor regarding its use in pregnancy.

breastfeeding
Reopro 10mg Injection is considered safe during breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | - |
Action Class | Glycoprotein IIb/IIIa inhibitors |
₹22629
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025